EcoDrugPlus

Adenosine A1 Receptor

Ensembl ID : ENSACLG00000007432
Gene Symbol: ADORA1
3 Cross references
208 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSACLG00000001615
Gene Symbol: ADORA2A
3 Cross references
188 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSACLG00000021225
Gene Symbol: ADORA2A
3 Cross references
200 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSACLG00000007096
Gene Symbol: ADORA2B
3 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSACLG00000022638
Gene Symbol: ADORA3
1 Cross references
226 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSACLG00000016918
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSACLG00000001934
Gene Symbol: LOC113013886
3 Cross references
201 Possible Orthologues:

Adenosine Receptor A3-Like

Ensembl ID : ENSACLG00000021782
Gene Symbol: LOC113021999
2 Cross references
230 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSACLG00000008785
Gene Symbol: ADRM1
3 Cross references
197 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSACLG00000010823
Gene Symbol: ADRA1AA
1 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSACLG00000007374
Gene Symbol: ADRA1B
3 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSACLG00000018077
Gene Symbol: ADRA1D
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).